| A1AT | Alpha-1-Antitrypsin |
| ApoA1 | Apolipoprotein A-I |
| ApoAC-22–ApoA4 | Apolipoprotein A-II to A-IV |
| ApoC1–C4 | Apolipoprotein C-I to C-IV |
| ApoD | Apolipoprotein D |
| ApoE | Apolipoprotein E |
| ApoL1 | Apolipoprotein L1 |
| ApoM | Apolipoprotein M |
| ANGT | Angiotensinogen |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| BMI | Body Mass Index |
| CAD | Coronary Artery Disease |
| CI | Confidence Interval |
| CIMT | Carotid Intima-Media Thickness |
| CLUS | Clusterin |
| CO3 | Complement Component 3 |
| DM | Diabetes Mellitus |
| FDR | False Discovery Rate |
| HDL | High-Density Lipoprotein |
| HDL-C | HDL Cholesterol |
| HOMA-IR | Homeostasis Model Assessment of Insulin Resistance |
| Hp | Haptoglobin |
| IR | Insulin Resistance |
| IRRS | Insulin Resistance Risk Score |
| KAIN | Kallistatin |
| LCAT | Lecithin Cholesterol Acyltransferase |
| LDL | Low-Density Lipoprotein |
| LDL-C | LDL Cholesterol |
| LpPLA2 | Lipoprotein-Associated Phospholipase A2 |
| LPL | Lipoprotein Lipase |
| PON1/PON3 | Paraoxonase 1/Paraoxonase 3 |
| PCAD | Prediction of Coronary Artery Disease (Score) |
| PIO | Pioglitazone |
| PLTP | Phospholipid Transfer Protein |
| PPAR-γ | Peroxisome Proliferator-Activated Receptor Gamma |
| RCT | Reverse Cholesterol Transport |
| RET4 | Retinol-Binding Protein 4 |
| SAA1/2, SAA4 | Serum Amyloid Alpha-1/2, Alpha-4 |
| SD | Standard Deviation |
| S1P | Sphingosine-1-Phosphate |
| SSPG | Steady-State Plasma Glucose |
| T2DM | Type 2 Diabetes Mellitus |
| TG | Triglycerides |
| TG/HDL-C | Triglyceride/HDL Cholesterol Ratio |
| TTHY | Transthyretin |
| VTNC | Vitronectin |
| WL | Weight Loss |